Madrigal Pharmaceuticals Inc (MDGL) — Capital Reinvestment Ratio

Latest as of September 2025: 0.01x

Madrigal Pharmaceuticals Inc (MDGL) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($79.85 Million) in capital expenditures ($857.00K). See how much free cash does Madrigal Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$79.85 Million
USD

Capital Expenditures

$857.00K
USD

Data as of

Sep 2025
Most recent filing

Madrigal Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2007)

This chart tracks Madrigal Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.

Annual Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc (2007–2007)

Year-by-year Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc from 2007 to 2007. For live market cap and broader valuation context, see Madrigal Pharmaceuticals Inc market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2007 0.09x $27.22 Million $2.35 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow